← Back to Search

SMArTVIEW for Cardiac Surgery (SMArTVIEW Trial)

N/A

Waitlist Available

Research Sponsored by McMaster University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥ 60 years;

Patient has undergone major cardiac or vascular surgery and has been admitted post-op to the surgical floor;

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion. an average of 1 year.

Awards & highlights

SMArTVIEW Trial Summary

This trial will test whether increased monitoring of patients after cardiac surgery leads to fewer hospital readmissions and emergency department visits.

Who is the study for?

This trial is for individuals aged 60 or older who have had major cardiac or vascular surgery and are expected to stay in the hospital for at least 48 hours post-op. They must be mentally clear (as shown by a negative CAM test) and able to consent on their own.Check my eligibility

What is being tested?

The SMArTVIEW program is being tested, which involves remote, automated monitoring of patients after cardiac or vascular surgery. The goal is to see if it reduces hospital readmissions and emergency visits within 45 days post-surgery compared to standard care.See study design

What are the potential side effects?

Since SMArTVIEW is a monitoring intervention rather than a medication, traditional side effects like those seen with drugs are not applicable. However, there may be issues related to privacy concerns or discomfort with technology use.

SMArTVIEW Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 60 years old or older.

Select...

I had major heart or blood vessel surgery and was admitted to the hospital afterwards.

Select...

I expect to stay in the hospital for surgery for at least 2 days.

SMArTVIEW Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion. an average of 1 year.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion. an average of 1 year.

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion. an average of 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Hospital Readmission Rate

Secondary outcome measures

Composite of Major Complications associated with Undetected Hemodynamic Compromise

Econometrics

Process & Implementation

+1 more

SMArTVIEW Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SMArTVIEWExperimental Treatment1 Intervention

Group II: Standard CareActive Control1 Intervention

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Population Health Research InstituteOTHER

155 Previous Clinical Trials

679,340 Total Patients Enrolled

McMaster UniversityLead Sponsor

879 Previous Clinical Trials

2,596,444 Total Patients Enrolled

Ontario Centres of ExcellenceIndustry Sponsor

4 Previous Clinical Trials

365 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment currently underway for this experiment?

"Unfortunately, this medical trial is not currently recruiting any patients. Originally posted on 21st March 2018 and last updated on 23rd August 2022, it has now ceased recruitment. However, 47 other clinical trials are actively seeking patient participation at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

THE SMArTVIEW, CoVeRed

2018. "THE SMArTVIEW, CoVeRed". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03253549.